These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 15941194)

  • 41. Biotech R&D goes further afield.
    Lawrence S
    Nat Biotechnol; 2006 Sep; 24(9):1052. PubMed ID: 16964201
    [No Abstract]   [Full Text] [Related]  

  • 42. The association of pharmaceutical company promotional spending with resident physician prescribing behavior.
    Huang FY; Weiss DS; Fenimore PG; Fleming AM; Haller E; Lichtmacher JE; Eisendrath SJ
    Acad Psychiatry; 2005; 29(5):500-1. PubMed ID: 16387978
    [No Abstract]   [Full Text] [Related]  

  • 43. Deconstructing Myogen's market cap.
    Ransom J
    Nat Biotechnol; 2006 Mar; 24(3):227-8. PubMed ID: 16525363
    [No Abstract]   [Full Text] [Related]  

  • 44. Biotech blockbusters consolidate markets.
    Lawrence S
    Nat Biotechnol; 2006 Dec; 24(12):1466. PubMed ID: 17160033
    [No Abstract]   [Full Text] [Related]  

  • 45. An audit of the results of the Roche Amplicor gonorrhoea test on female genital samples--a cheaper and more sensitive method than culture in an urban English population.
    Hardwick C; White D; Osman H
    Int J STD AIDS; 2007 May; 18(5):347-8. PubMed ID: 17524199
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Path to approval proves rocky for copycat biodrugs.
    Wadman M
    Nature; 2005 Nov; 438(7065):154-5. PubMed ID: 16281004
    [No Abstract]   [Full Text] [Related]  

  • 47. The threats and challenges of REACH.
    European Diagnostic Manufacturers Association
    Med Device Technol; 2005 Dec; 16(10):24-5. PubMed ID: 16419922
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cutting costs of prolactin estimations in dried blood on filter paper.
    Mitchell ML; Hermos RJ
    Clin Chem; 1986 Sep; 32(9):1789-90. PubMed ID: 3742807
    [No Abstract]   [Full Text] [Related]  

  • 49. Sigma diagnostics: pioneer of kits for clinical chemistry.
    Berger L
    Clin Chem; 1993 May; 39(5):902-3. PubMed ID: 8485885
    [No Abstract]   [Full Text] [Related]  

  • 50. Diagnostic tests for HIV resistance are created as quickly as the new drugs. Research is leading individualized medicine evolution.
    AIDS Alert; 2006 Sep; 21(9):97-9. PubMed ID: 17019780
    [No Abstract]   [Full Text] [Related]  

  • 51. Abbott Laboratories and Celera Diagnostics form alliance.
    Expert Rev Mol Diagn; 2002 Jul; 2(4):295. PubMed ID: 12138485
    [No Abstract]   [Full Text] [Related]  

  • 52. Drug evaluation and approval process in the European Union.
    San Miguel MT; Vargas E
    Arthritis Rheum; 2006 Feb; 55(1):12-4. PubMed ID: 16463405
    [No Abstract]   [Full Text] [Related]  

  • 53. New-wave diagnostics.
    Baker M
    Nat Biotechnol; 2006 Aug; 24(8):931-8. PubMed ID: 16900134
    [No Abstract]   [Full Text] [Related]  

  • 54. Top 20 pharmaceutical companies. Ranked by U.S. sales, December 2005 to November 2006.
    Mod Healthc; 2007 Jan; 37(2):33. PubMed ID: 17243346
    [No Abstract]   [Full Text] [Related]  

  • 55. Market watch: sales trends by therapeutic area: 2008-2013E.
    Goodman M
    Nat Rev Drug Discov; 2009 Sep; 8(9):689. PubMed ID: 19721440
    [No Abstract]   [Full Text] [Related]  

  • 56. [Current state and development trends of domestic medical device market for in vitro diagnostics in the segment of diagnostic reagents and their kits.].
    Mardanly SG
    Klin Lab Diagn; 2019; 64(7):443-448. PubMed ID: 31408598
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The immunochemical faecal occult blood test leads to higher compliance than the guaiac for colorectal cancer screening programmes: a cluster randomized controlled trial.
    Federici A; Giorgi Rossi P; Borgia P; Bartolozzi F; Farchi S; Gausticchi G
    J Med Screen; 2005; 12(2):83-8. PubMed ID: 15949119
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Has the introduction of the European Parliament Directive 98/79/EC from 1998-10-27--concerning in-vitro diagnostic devices (IVD-directive) influenced performance of hormone immunoassay kits in terms of precision and accuracy? Results from selected external quality assessment (EQA) schemes between 1993 and 2008.
    Wood WG
    Clin Lab; 2009; 55(3-4):86-105. PubMed ID: 19462931
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Biotech as an employer.
    Lawrence S
    Nat Biotechnol; 2007 Jan; 25(1):12. PubMed ID: 17211380
    [No Abstract]   [Full Text] [Related]  

  • 60. GAO report says drug R & D costs rising, innovation decreasing.
    Consult Pharm; 2007 Mar; 22(3):257-8. PubMed ID: 17691159
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.